Anti-MYD88 monoclonal antibody

Pre-made anti-MYD88 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MYD88/MYD88 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T75476-Ab-1/ GM-Tg-hg-T75476-Ab-2Anti-Human MYD88 monoclonal antibodyHuman
GM-Tg-rg-T75476-Ab-1/ GM-Tg-rg-T75476-Ab-2Anti-Rat MYD88 monoclonal antibodyRat
GM-Tg-mg-T75476-Ab-1/ GM-Tg-mg-T75476-Ab-2Anti-Mouse MYD88 monoclonal antibodyMouse
GM-Tg-cynog-T75476-Ab-1/ GM-Tg-cynog-T75476-Ab-2Anti-Cynomolgus/ Rhesus macaque MYD88 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T75476-Ab-1/ GM-Tg-felg-T75476-Ab-2Anti-Feline MYD88 monoclonal antibodyFeline
GM-Tg-cang-T75476-Ab-1/ GM-Tg-cang-T75476-Ab-2Anti-Canine MYD88 monoclonal antibodyCanine
GM-Tg-bovg-T75476-Ab-1/ GM-Tg-bovg-T75476-Ab-2Anti-Bovine MYD88 monoclonal antibodyBovine
GM-Tg-equg-T75476-Ab-1/ GM-Tg-equg-T75476-Ab-2Anti-Equine MYD88 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T75476-Ab-1/ GM-Tg-hg-T75476-Ab-2; GM-Tg-rg-T75476-Ab-1/ GM-Tg-rg-T75476-Ab-2;
GM-Tg-mg-T75476-Ab-1/ GM-Tg-mg-T75476-Ab-2; GM-Tg-cynog-T75476-Ab-1/ GM-Tg-cynog-T75476-Ab-2;
GM-Tg-felg-T75476-Ab-1/ GM-Tg-felg-T75476-Ab-2; GM-Tg-cang-T75476-Ab-1/ GM-Tg-cang-T75476-Ab-2;
GM-Tg-bovg-T75476-Ab-1/ GM-Tg-bovg-T75476-Ab-2; GM-Tg-equg-T75476-Ab-1/ GM-Tg-equg-T75476-Ab-2
Products NameAnti-MYD88 monoclonal antibody
Formatmab
Target NameMYD88
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MYD88 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T75476-Ag-1Recombinant multi-species MYD88/ MYD88D protein
    ORF Viral VectorvGMLV000373human MYD88 Lentivirus particle
    ORF Viral VectorpGMLV000373human MYD88 Lentivirus plasmid
    ORF Viral VectorpGMLPm001937mouse Myd88 Lentivirus plasmid
    ORF Viral VectorvGMLPm001937mouse Myd88 Lentivirus particle


    Target information

    Target IDGM-T75476
    Target NameMYD88
    Gene ID4615,17874,301059,696494,477024,101087092,444881,100053940
    Gene Symbol and SynonymsIMD68,MYD88,MYD88D,WM1
    Uniprot AccessionQ99836,Q6Y1S1,B3Y683,Q599T9
    Uniprot Entry NameMYD88_HUMAN,MYD88_MACMU,MYD88_RAT,MYD88_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000172936
    Target ClassificationTumor-associated antigen (TAA)

    The target: MYD88, gene name: MYD88, also named as MYD88D. This gene encodes a cytosolic adapter protein that plays a central role in the innate and adaptive immune response. This protein functions as an essential signal transducer in the interleukin-1 and Toll-like receptor signaling pathways. These pathways regulate that activation of numerous proinflammatory genes. The encoded protein consists of an N-terminal death domain and a C-terminal Toll-interleukin1 receptor domain. Patients with defects in this gene have an increased susceptibility to pyogenic bacterial infections. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.